Streamline Dermatology Real-Time Eligibility (270/271) for Biologics and Mohs Surgery

Klivira automates **dermatology real-time eligibility (270/271)** checks, ensuring accurate patient coverage verification for high-cost biologics and complex procedures like Mohs surgery at the point of service.

For dermatology practices, managing patient eligibility is critical, particularly given the prevalence of high-cost biologics and specialized surgical procedures. Stale eligibility data can lead to significant revenue leakage and administrative burden. Proactive, real-time verification prevents day-of-service surprises, optimizing financial clearance workflows for your revenue cycle teams.

The Criticality of Real-Time Eligibility in Dermatology

Dermatology practices frequently manage conditions requiring expensive, long-term treatments such as biologics for psoriasis or atopic dermatitis, and specialized procedures like Mohs micrographic surgery. Without real-time eligibility checks, coverage changes between scheduling and the date of service can lead to unexpected denials and increased manual work, directly impacting the financial health of the practice.

Dermatology Services Driving Eligibility Requirements

Biologics for psoriasis, psoriatic arthritis, and atopic dermatitis (e.g., Dupixent, Cosentyx, Tremfya, Skyrizi).
Specialty topicals and oral targeted therapies.
Mohs micrographic surgery for non-melanoma skin cancers.
Advanced skin cancer treatments, including immunotherapies.
Phototherapy, especially when prescribed for home administration.
Specific biopsy and excision codes that may trigger PA requirements.

Addressing Stale Data and Day-of-Service Surprises

Traditional batch eligibility checks performed at scheduling often result in stale data by the time of service. In dermatology, this can mean a patient arrives for a crucial biologic infusion or Mohs procedure only to discover their coverage has lapsed or changed. Klivira's event-driven real-time eligibility addresses these challenges by verifying coverage precisely when it's needed most, such as at patient check-in or prior to order entry.

Klivira's Real-Time Eligibility for Dermatology

Klivira integrates directly into your EMR to provide immediate eligibility verification. Our platform leverages both X12 270 real-time transactions and FHIR Coverage queries, ensuring comprehensive and up-to-date information. This proactive approach not only confirms patient coverage but also initiates prior authorization workflows immediately if a PA requirement for a planned same-day service is identified.

Optimizing Dermatology Financial Clearance

Reduced claim denials due to invalid or expired coverage.
Elimination of manual portal lookups for eligibility verification.
Improved patient experience by preventing day-of-service coverage surprises.
Streamlined workflows for high-volume procedures like Mohs surgery.
Proactive identification of prior authorization requirements for biologics.
Enhanced financial predictability for chronic biologic treatment plans.

EMR Integration and Payer Connectivity for Dermatology

Klivira seamlessly integrates with leading EMR systems, surfacing eligibility details directly within your registration and check-in workflows. Our robust connectivity extends to numerous payers, supporting real-time X12 270/271 exchanges and FHIR-based queries. This ensures that dermatology practices have immediate access to comprehensive eligibility data, reducing administrative overhead and accelerating patient access to care.

Standards and Compliance Considerations

Klivira's real-time eligibility solution adheres to industry standards such as X12 270/271 and FHIR Coverage, facilitating secure and efficient data exchange. While these standards enhance operational efficiency, practices should consult with their compliance teams regarding HIPAA and ePHI handling, ensuring all automated processes align with internal policies and regulatory requirements.

Frequently asked questions

How does real-time eligibility specifically benefit dermatology practices managing biologics?

For high-cost biologics used in conditions like psoriasis or atopic dermatitis, real-time eligibility ensures that patient coverage is active and appropriate for the specific drug. This prevents costly denials, reduces the need for retroactive appeals, and confirms that step therapy requirements (if applicable to coverage) are aligned with current benefits before treatment initiation.

Can real-time eligibility help with Mohs micrographic surgery procedures?

Yes, real-time eligibility is crucial for Mohs surgery. It verifies coverage for the procedure at check-in, preventing situations where a patient undergoes surgery only for eligibility issues to surface later. This also helps pre-emptively identify if a prior authorization is required for Mohs based on payer-specific policies, aligning with AAD Appropriate Use Criteria.

How does Klivira integrate real-time eligibility into our existing EMR system?

Klivira integrates via event-driven triggers, such as patient registration or appointment check-in, to automatically query eligibility. The verified data is then surfaced directly within your EMR's existing workflows, providing front desk and scheduling staff with immediate, actionable insights without requiring them to navigate external portals.

Does Klivira's system handle re-authorization needs for chronic dermatology conditions?

While real-time eligibility focuses on current coverage, Klivira's broader platform addresses the periodic re-authorization cycles common for chronic biologic treatments. By identifying current eligibility, the system can then flag and initiate the necessary prior authorization workflows for ongoing care, streamlining the re-authorization process to prevent treatment gaps.

What industry standards does Klivira use for real-time eligibility?

Klivira utilizes standard X12 270/271 transactions for real-time eligibility inquiries and responses, which are widely supported by clearinghouses and payers. Additionally, for payers with modern interfaces, Klivira queries FHIR Coverage endpoints, aligning with evolving industry standards like those promoted by CMS-0057-F.